Skip to main content

Month: March 2026

CVB Financial Corp. Announces 146th Consecutive Quarterly Cash Dividend

Ontario, CA, March 18, 2026 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the first quarter of 2026. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on March 18, 2026. The quarterly dividend will be payable on or about April 15, 2026, to shareholders of record as of April 01, 2026. “Our consistent and strong financial performance has enabled the Bank to announce our 146th consecutive quarterly cash dividend to be paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate OverviewCVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank, National Association. CVBF is one of the 10 largest bank holding companies headquartered in California...

Continue reading

Alvotech Q4 2025 and Full Year 2025 Financial Results

REYKJAVIK, Iceland, March 18, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights  A supplemental long‑form earnings release providing additional operational details and business update for Q4 2025 and the full year is available at: https://investors.alvotech.com/earnings-calendar The supplemental document is provided solely for reference and is not part of this SEC Form 6‑K. The Form 6‑K should not be read together with, or construed as referring to, the supplemental long‑form release. Q4 2025 HighlightsTotal revenues1 were $173 million, up 13% Year-on-Year (YoY) Adjusted EBITDA1 was $69 million with Gross Margin at 66% AVT05 was approved as a biosimilar to Simponi® in the UK and European Economic Area (EEA) AVT03 was approved as a biosimilar to Prolia® and Xgeva® in the...

Continue reading

Alvotech Q4 2025 and Full Year 2025 Financial Results

A supplemental long‑form earnings release providing additional operational details and business update for Q4 2025 and the full year is available at: https://investors.alvotech.com/earnings-calendar The supplemental document is provided solely for reference and is not part of this SEC Form 6‑K. The Form 6‑K should not be read together with, or construed as referring to, the supplemental long‑form release. Financial Highlights  Q4 2025 HighlightsTotal revenues1 were $173 million, up 13% Year-on-Year (YoY) Adjusted EBITDA1 was $69 million with Gross Margin at 66% AVT05 was approved as a biosimilar to Simponi® in the UK and European Economic Area (EEA) AVT03 was approved as a biosimilar to Prolia® and Xgeva® in the EEA The EMA accepted for review a marketing application for AVT23, referencing Xolair® After the end of the quarter, Alvotech...

Continue reading

Future Mineral Closes Second Tranche of Private Placement

TORONTO, March 18, 2026 (GLOBE NEWSWIRE) — Future Mineral Resources Inc. (“Future Mineral” or the “Company”) (TSX: FMR) is pleased to announce that it has closed a second tranche (the “Second Tranche”) of a previously announced non-brokered private placement financing of up to 15 million common shares at a price of $0.30 per share for gross proceeds of up to $4.5m (the “Offering”). For more information about the Offering and first tranche closing (the “First Tranche”), please see the Company’s press releases dated January 7, 2026, February 2, 2026, and March 13, 2026, each of which is available under the Company’s SEDAR+ profile at www.sedarplus.ca. Pursuant to the Second Tranche, Future Mineral issued 316,667 common shares at a price of $0.30 per share for gross proceeds of approximately $95,000. The securities issued in connection...

Continue reading

Petrus Resources Announces Fourth Quarter and Year-End 2025 Financial, Operating & Reserves Results

CALGARY, Alberta, March 18, 2026 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to report financial and operating results as at and for the three months and year ended December 31, 2025, and to provide 2025 year-end reserves information as evaluated by Insite Petroleum Consultants Ltd. (“Insite”). The Company’s Management’s Discussion and Analysis (“MD&A”) and audited consolidated financial statements are available on SEDAR+ at www.sedarplus.ca. Q4 2025 HIGHLIGHTS:Funds flow(2) up 8% – Generated funds flow of $13.5 million(2) in the fourth quarter of 2025, an 8% increase from $12.5 million reported in the fourth quarter of 2024. The increase is due to higher production volumes, increased realized gains from risk management activities, and lower...

Continue reading

Cavvy Energy Releases 2025 Q4 and Full Year Financial and Operating Results, 2025 Reserves, and Repays US$27 Million Debt in Q1 2026

Third-Party Processing Growth and Hedging Gains Drive Debt Reduction; Strong Sulphur Prices Support Increase in Reserve Value Not For Distribution to United States News Wire Services or Dissemination in United States CALGARY, Alberta, March 18, 2026 (GLOBE NEWSWIRE) — Cavvy Energy Ltd. (“Cavvy” or the “Company”) (TSX:CVVY) is pleased to announce the release of its fourth quarter and full year 2025 financial and operating results. The Company produced 23,904 boe/d and generated Net Operating Income1 (“NOI”) of $110.5 million during 2025. The Company produced 23,003 boe/d and generated NOI of $20.8 million during the fourth quarter of 2025 with an exit production rate of 24,569 boe/d. During the first quarter of 2026, Cavvy repaid US$27.0 million of long-term debt, resulting in an undrawn senior revolving facility (US$22.0 million...

Continue reading

Wintrust Financial Corporation Announces First Quarter 2026 Earnings Release Schedule

ROSEMONT, Ill., March 18, 2026 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”) (Nasdaq: WTFC) today announced it will release first quarter 2026 earnings results after the market closes on Monday, April 20, 2026, and host a conference call on Tuesday, April 21, 2026, at 10:00 a.m. CDT.  For individuals wanting to listen to a simultaneous audio-only web cast, this may be accessed at Webcast Link. Individuals interested in participating in the call by addressing questions to management should register for the call at Conference Call Link to receive a dial-in number and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes prior to the event start (although you may register and dial in at any time during the call). An accompanying slide presentation will be available on the...

Continue reading

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today announced corporate updates and financial results for the year ended December 31, 2025. “In 2025, we continued to advance MT-601, our lead Multi-Antigen...

Continue reading

Twin Peaks and Dos Equis Launch $2 Million Bracket Challenge for 2026 Tournament Season

One winner per lodge gets $50 gift card and a shot at ‘dos’ million for a perfect bracket DALLAS, March 18, 2026 (GLOBE NEWSWIRE) — As tournament season approaches, Twin Peaks Restaurant is once again raising the stakes with the return of its annual Dos Million Bracket Challenge, presented by Dos Equis. Basketball fans 21 and older can register now at TwinPeaksBracketChallenge.com for a chance to win $2 million for a perfect bracket.* For fans searching where to watch the action or planning a watch party, Twin Peaks lodges across the country will serve as headquarters for bracket competitions, game-day food and wall-to-wall viewing throughout the tournament. In addition to the national grand prize, Twin Peaks is bringing the competition closer to home. The top bracket at every participating lodge will win a $50 Twin Peaks gift...

Continue reading

Actelis Networks Reports 2025 Financial Results Highlighted by Strong Fourth Quarter Rebound

Fourth quarter revenue more than doubles sequentially with improved margins; Company continues to expand its footprint across key sectors SUNNYVALE, Calif, March 18, 2026 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today reported its financial results for the full year ended December 31, 2025, and provided business and corporate updates. Revenues for the fourth quarter of 2025 were approximately $1.4 million, representing an increase of 113% from $0.64 million in the third quarter of 2025. For the full year 2025, revenues were $3.7 million, compared to $7.8 million in the prior year. The decrease was primarily driven by two large deals in 2024 that did not...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.